EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and survival implications of malnutrition and sarcopenia in metastatic breast cancer: A longitudinal analysis

Géraldine M Camilleri, Lidia Delrieu, Carole Bouleuc, Jean-Yves Pierga, Paul Cottu, Frédérique Berger, Bruno Raynard, Stacy Cyrille, Timothée Marchal

Clinical Nutrition · 2024

DOI: 10.1016/j.clnu.2024.06.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2024. Verfasst von Géraldine M Camilleri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Supportive Care, Institut Curie, 75005 Paris, France. Electronic address: geraldine.camilleri@curie.fr. Hauptthemen laut MEDLINE: Sarcopenia, Malnutrition, Breast Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Malnutrition and sarcopenia are challenges for patients with metastatic breast cancer and have been proposed as independent prognostic factors. Very few studies have addressed the temporal evolution of these parameters and, notably, the separate and combined analysis of sarcopenia and malnutrition. This study aimed to i) determine the prevalence of malnutrition and sarcopenia, individually and combined, and their evolution over time, ii) identify risk factors for each condition, and iii) explore their impact on overall survival (OS). METHODS: This retrospective study was conducted on 111 patients treated for at least a third-line metastatic breast cancer at the Institut Curie between January 1st and March 31st, 2018. Solitary malnutrition was defined from weight loss and body mass index values while solitary sarcopenia was defined solely based on low muscle mass. We analyzed solitary malnutrition, solitary sarcopenia, and then malnutrition with or without sarcopenia, at three key stages (T1: diagnosis of metastasis, T2: initiation of third-line treatment, and T3: 3-month re-evaluation). Univariate and multivariate logistic regression analyses were conducted to investigate the risk factors. We performed Cox proportional hazards analyses for each variable. RESULTS: At T1, the prevalence of solitary malnutrition, solitary sarcopenia and malnutrition with or without sarcopenia was 18.6%, 36.1% and 48.9% respectively, increasing to 27.7%, 45.5% and 56.6% at T2. At T2, in multivariate logistic regression analyses, patients aged over 60 years were at an elevated risk of experiencing solitary malnutrition as well as malnutrition with or without sarcopenia, but not solitary sarcopenia. In multivariate analyses, solitary malnutrition was significantly associated with poorer OS (HR 2.2 [95% CI 1.1-4.1], p = 0.02), while solitary sarcopenia and malnutrition with or without sarcopenia showed no association. CONCLUSION: Solitary malnutrition and sarcopenia were highly prevalent in patients with metastatic breast cancer, affecting around a quarter and half of patients respectively at third-line treatment initiation. Notably, solitary malnutrition emerged as a prognostic factor for overall survival, whereas no significant association was observed for solitary sarcopenia or malnutrition with or without sarcopenia. This highlights the critical need for early identification of patients at risk of malnutrition and the importance of timely intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaMalnutritionBreast NeoplasmsHumansFemalePrevalenceRetrospective StudiesMiddle AgedAgedRisk FactorsLongitudinal StudiesNeoplasm MetastasisAdultPrognosisBody Mass Index

Stichwörter der Autor:innen

Breast neoplasmsMalnutritionSarcopeniaSurvival

Autor:innen und Institutionen

  • Department of Supportive Care, Institut Curie, 75005 Paris, France. Electronic address: geraldine.camilleri@curie.fr.
  • Residual Tumour & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, Paris University, 75005 Paris, France; Institute for Biomedical and Epidem…
  • Department of Supportive Care, Institut Curie, 75005 Paris, France.
  • Department of Medical Oncology, Institut Curie, 26 Rue d'Ulm, 75005, Paris, France; Circulating Tumor Biomarkers laboratory, Inserm CIC-BT 1428, Institut Curie, Paris France; Université Paris Cité, France.
  • Department of Medical Oncology, Institut Curie, 26 Rue d'Ulm, 75005, Paris, France.
  • Institut Curie, PSL Research University, DREH, Department of Biometrics, Saint-Cloud, France.

Zitieren

APA

Camilleri, G. M., Delrieu, L., Bouleuc, C., Pierga, J. Y., Cottu, P., Berger, F., Raynard, B., Cyrille, S., & Marchal, T. (2024). Prevalence and survival implications of malnutrition and sarcopenia in metastatic breast cancer: A longitudinal analysis. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2024.06.014

Vancouver

Camilleri GM, Delrieu L, Bouleuc C, Pierga JY, Cottu P, Berger F, et al. Prevalence and survival implications of malnutrition and sarcopenia in metastatic breast cancer: A longitudinal analysis. Clinical Nutrition. 2024. doi:10.1016/j.clnu.2024.06.014

BibTeX
@article{Camilleri2024,
  author = {Camilleri, Géraldine M and Delrieu, Lidia and Bouleuc, Carole and Pierga, Jean-Yves and Cottu, Paul and Berger, Frédérique and Raynard, Bruno and Cyrille, Stacy and Marchal, Timothée},
  title = {Prevalence and survival implications of malnutrition and sarcopenia in metastatic breast cancer: A longitudinal analysis},
  journal = {Clinical Nutrition},
  year = {2024},
  doi = {10.1016/j.clnu.2024.06.014}
}
Kostenlos starten →